Improvement in HOMA-IR is an independent predictor of reduced carotid intima-media thickness in obese adolescents participating in an interdisciplinary weight-loss program

Hypertens Res. 2011 Feb;34(2):232-8. doi: 10.1038/hr.2010.225. Epub 2010 Dec 2.

Abstract

The aim of this study was to verify whether a 1-year interdisciplinary weight-loss program improved common carotid artery intima-media thickness (IMT) and whether insulin resistance and/or inflammation (as measured by the markers plasminogen activator inhibitor type-1 and adiponectin) might underlie obesity in adolescents. A group of 29 post-pubescent obese adolescents were submitted to an interdisciplinary intervention over the course of 1 year. Common carotid artery IMT was determined ultrasonographically. Body composition, blood pressure (BP), glycemia, insulinemia, homeostasis model assessment of insulin resistance (HOMA-IR), lipid profile and adipokine concentrations were analyzed before and after the intervention. The interdisciplinary weight-loss program promoted a significant improvement in body composition, insulin concentration, HOMA-IR, lipid profile, BP and inflammatory state, in addition to significantly decreasing the common carotid artery IMT. Furthermore, this study demonstrated that the difference between baseline and final values of HOMA-IR (ΔHOMA-IR) was negatively correlated with concomitant changes in the adiponectin concentration (Δadiponectin; r=-0.42; P=0.02) and positively correlated with changes in common carotid artery IMT (Δcarotid IMT; r=0.41; P=0.03). Multiple regression analysis adjusted by age, cardiovascular risk factors and inflammatory markers showed that ΔHOMA-IR was an independent predictor of significant changes in common carotid artery IMT. This investigation demonstrated that an interdisciplinary weight-loss program promoted a reduction of the common carotid artery IMT in obese Brazilian adolescents, and the improvement of HOMA-IR was an independent predictor of carotid IMT changes in this population.

Publication types

  • Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipokines / blood
  • Adiponectin / blood
  • Adolescent
  • Blood Glucose / physiology
  • Blood Pressure / physiology
  • Brazil
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control
  • Diet, Reducing*
  • Exercise*
  • Female
  • Humans
  • Insulin / blood
  • Insulin Resistance*
  • Lipids / blood
  • Male
  • Obesity / diet therapy
  • Obesity / pathology
  • Obesity / therapy*
  • Plasminogen Activator Inhibitor 1 / blood
  • Psychotherapy
  • Tunica Intima / diagnostic imaging*
  • Tunica Intima / pathology
  • Ultrasonography
  • Weight Loss*

Substances

  • Adipokines
  • Adiponectin
  • Blood Glucose
  • Insulin
  • Lipids
  • Plasminogen Activator Inhibitor 1